I-L -ptptophan

Umxholo

• Kusenokwenzeka ukuba ayisebenzi ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

I-tryptophan yi-amino acid. Ii-amino acid ziibhloko zokwakha iiproteni. I-tryptophan ibizwa ngokuba yi "amino acid" ebalulekileyo kuba umzimba awukwazi ukuyenza ngokwawo. Kufuneka ifunyanwe ekutyeni. I-tryptophan ityiwa njengenxalenye yokutya kwaye inokufumaneka kukutya okune-protein.

Abantu basebenzisa i-L-tryptophan kwiimpawu ezinzima ze-PMS (premenstrual dysphoric disorder okanye i-PMDD), ukusebenza kwezemidlalo, ukudakumba, ukulala, kunye nezinye iimeko ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe L-TRYPTOPHAN zezi zilandelayo:

Kusenokwenzeka ukuba ayisebenzi ...

• Ukugaya amazinyo (bruxism). Ukuthatha i-L-tryptophan ngomlomo akuncedi ukunyanga ukugaya amazinyo.
• Imeko ebangela iintlungu eziqhubekayo zemisipha (myofascial pain syndrome). Ukuthatha i-L-tryptophan ngomlomo akuncedi ukunciphisa olu hlobo lwentlungu.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Ukusebenza kwezemidlalo. Olunye uphando lubonisa ukuba ukuthatha i-L-tryptophan kangangeentsuku ezi-3 ngaphambi kokuzilolonga kunokuphucula amandla ngexesha lokuzilolonga. Olu phuculo kumandla lunceda ukonyusa umgama imbaleki enokuya ngayo kwixesha elifanayo. Kodwa olunye uphando lwangaphambili lubonisa ukuba ukuthatha i-L-tryptophan ngexesha lokuzilolonga akuphuculi unyamezelo ngexesha lokuzilolonga ngebhayisikile. Izizathu zeziphumo ezingqubanayo azicacanga. Kungenzeka ukuba i-L-tryptophan iphucule amanyathelo athile emidlalo kodwa hayi amanye. Ngakolunye uhlangothi, i-L-tryptophan ingadinga ukuba ithathwe iintsuku ezimbalwa ngaphambi kokuzivocavoca ukuze ibone nayiphi na inzuzo.
• Ukuqwalaselwa kwentsilelo-yokuchaphazeleka kwengqondo (ADHD). Kukho ubungqina bokuba amanqanaba e-L-tryptophan asezantsi kubantwana abane-ADHD. Kodwa ukuthatha i-L-tryptophan supplements akubonakali ukuphucula iimpawu ze-ADHD.
• Uxinzelelo. Uphando lwakwangoko lubonisa ukuba i-L-tryptophan inokuphucula ukusebenza kwamayeza aqhelekileyo kuxinzelelo.
• Fibromyalgia. Uphando lwakwangoko lubonisa ukuba ukongeza ii-walnuts kukutya kweMeditera ukubonelela ngakumbi nge-L-tryptophan kunye ne-magnesium kunokuphucula uxinzelelo kunye nezinye iimpawu ze-fibromyalgia.
• Usulelo lokugaya olunokukhokelela kwizilonda (Helicobacter pylori okanye H. pylori). Uphando lubonisa ukuba ukuthatha i-L-tryptophan ngokudibanisa neyeza lesilonda i-omeprazole kuphucula amanqanaba okuphilisa izilonda xa kuthelekiswa nokuthatha i-omeprazole yodwa.
• Ukuphuthelwa. Ukuthatha i-L-tryptophan kunokunciphisa ixesha elithathayo ukulala kunye nokuphucula imeko yabantu abasempilweni abaneengxaki zokulala. Ukuthatha i-L-tryptophan kunokuphucula ukulala kubantu abaneengxaki zokulala ezinxulumene nokurhoxa kweziyobisi ezingekho mthethweni.
• Migraine. Uphando lwakwangoko lufumene ukuba amanqanaba asezantsi e-L-tryptophan ekutyeni kunxulunyaniswa nomngcipheko owandayo we-migraine.
• Iimpawu ezinzima ze-PMS (i-premenstrual dysphoric disorder okanye i-PMDD). Ukuthatha i-6 gram ye-L-tryptophan ngemini kubonakala kunciphisa ukutshintsha kwemozulu, uxinzelelo kunye nokucaphuka kwabasetyhini abane-PMDD.
• Uxinzelelo lwamaxesha onyaka (ukuphazamiseka okwenzeka ngexesha lonyaka okanye i-SAD). Uphando lwakwangoko lubonisa ukuba i-L-tryptophan inokuba luncedo kwi-SAD.
• Ingxaki yokulala apho abantu bayeke ukuphefumula okwesikhashana xa belele (i-apnea yokulala). Kukho ubungqina bokuba ukuthatha i-L-tryptophan kunokunciphisa iziqendu kwabanye abantu abanendlela ethile yale meko, ebizwa ngokuba yi-obstructive sleep apnea (OSA).
• Ukuyeka ukutshaya. Ukuthatha i-L-tryptophan kunye nonyango oluqhelekileyo kunokunceda abanye abantu bayeke ukutshaya.
• Ixhala.
• Ukuhla kwenkumbulo kunye nezakhono zokucinga kubantu abadala ezingaphezulu kokuqhelekileyo kubudala babo.
• Igawuthi.
• Isifo se-Premenstrual syndrome (PMS).
• Isifo seTourette.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala i-L-tryptophan kwezi zinto zisetyenziswayo.

I-tryptophan ifumaneka ngokwendalo kwiiproteni zezilwanyana kunye nezityalo. I-tryptophan ithathwa njenge-amino acid ebalulekileyo kuba imizimba yethu ayinako ukuyenza. Kubalulekile kuphuhliso kunye nokusebenza kwamalungu amaninzi emzimbeni. Emva kokufunxa i-L-tryptophan ekutyeni, imizimba yethu iguqula enye ibe yi-5-HTP (5-hyrdoxytryptophan), emva koko iye kwi-serotonin. Imizimba yethu ikwaguqula enye i-L-tryptophan iye kwi-niacin (ivithamini B3). ISerotonin yincindi yedlala ehambisa imiqondiso phakathi kweeseli zemithambo-luvo. Ikwabangela ukuba imithambo yegazi icuthe. Utshintsho kwinqanaba le-serotonin kwingqondo inokutshintsha imeko. Xa kuthathwa ngomlomo: I-tryptophan yile UKHUSELEKO OLUNOKWENZEKA xa kuthathwa ngomlomo, ixesha elifutshane. I-tryptophan inokubangela iziphumo ebezingalindelekanga ezinjengokutsha kwentliziyo, iintlungu zesisu, ukubamba kunye negesi, isicaphucaphu, ukugabha, urhudo, kunye nelahleko lokutya. Inokubangela nentloko ebuhlungu, ukomelela, ukozela, umlomo owomileyo, ukungaboni kakuhle, ukuba buthathaka kwezihlunu kunye neengxaki zesondo kwabanye abantu. Ngo-1989, i-L-tryptophan yayixhunyaniswe neengxelo ezingaphezu kwe-1500 ze-eosinophilia-myalgia syndrome (EMS) kunye nokufa kwabantu abangama-37. I-EMS yimeko ye-neurological ebangela iimpawu ezininzi ezahlukeneyo. Ezi mpawu zihlala ziphucula ngokuhamba kwexesha, kodwa abanye abantu banokufumana iimpawu ukuya kuthi ga kwiminyaka emi-2 emva kokuba bephuhlise i-EMS. Ngo-1990, uL-tryptophan wayekhunjulwa kwiimarike ngenxa yezi nkxalabo zokhuseleko. Isizathu ngqo se-EMS kwizigulana ezithatha i-L-tryptophan asaziwa, kodwa obunye ubungqina bubonisa ukuba kungenxa yongcoliseko. Malunga ne-95% yazo zonke iimeko ze-EMS zalandelwa kwi-L-tryptophan eveliswe ngumenzi omnye eJapan. Okwangoku, phantsi komthetho weDiary Supplement Health and Education Act (DSHEA) ka-1994, iL-tryptophan iyafumaneka kwaye ithengiswa njengesongezelelo sokutya eMelika.

Akukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba i-L-tryptophan ikhuselekile xa ithathwa ngomlomo ixesha elide.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: I-tryptophan yile NGOKUFANELEKILEYO ekukhulelweni kuba inokwenzakalisa umntwana ongekazalwa. Akukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba ngaba i-L-tryptophan ikhuselekile ekusebenziseni xa uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe i-L-tryptophan ngexesha lokukhulelwa kunye nokuncancisa.

Mkhulu

Sukuyithatha le indibaniselwano.

Amayeza okudambisa (i-CNS depressants)

I-L-tryptophan inokubangela ukulala nokozela. Amayeza abangela ubuthongo abizwa ngokuba kukuthomalalisa. Ukuthatha i-L-tryptophan kunye namayeza okuthambisa kunokubangela ukulala kakhulu.

Amanye amayeza okuthambisa afaka i-clonazepam (iKlonopin), i-lorazepam (Ativan), i-phenobarbital (i-Donnatal), i-zolpidem (i-Ambien) kunye nezinye.

Iphakathi

Lumka ngale nhlanganisela.

Iziyobisi zeSerotonergic

I-tryptophan inyusa ikhemikhali kwingqondo ebizwa ngokuba yi-serotonin. Amanye amayeza anyusa ne-serotonin. Ukuthatha i-L-tryptophan kunye nala mayeza kunokunyusa i-serotonin kakhulu. Oku kunokubangela iziphumo ebezingalindelekanga ezibi kubandakanya intloko ebukhali, iingxaki zentliziyo, ukungcangcazela, ukudideka kunye noxinzelelo.

Amanye ala mayeza aquka i-fluoxetine (Prozac), i-paroxetine (i-Paxil), i-sertraline (i-Zoloft), i-amitriptyline (i-Elavil), i-clomipramine (i-Anafranil), i-imipramine (i-Tofranil), i-sumatriptan (Imitrex), i-zolmitriptan (i-Zomig), i-rizatriptan methadone (Dolophine), tramadol (Ultram), kunye nezinye ezininzi.

Iherbs kunye nezongezelelo ezineempawu zokuthomalalisa

I-tryptophan inokubangela ukozela kunye nokuphumla. Ukuyisebenzisa kunye namanye amayeza kunye nezongezo ezineziphumo zokuthomalalisa kunokubangela ukozela kakhulu. Ezinye zale mifuno kunye nezongezelelo zibandakanya i-5-HTP, i-calamus, i-poppy yaseCalifornia, i-catnip, i-hops, i-dogwood yaseJamaican, i-kava, i-wort yase-St.

Iherbs kunye nezongezo ezineepropathi ze-serotonergic

I-tryptophan ibonakala iphakamisa inqanaba le-serotonin, ihormoni ehambisa imiqondiso phakathi kweeseli zemithambo-luvo kwaye ichaphazele imeko. Kukho inkxalabo yokuba ukuyisebenzisa ngamanye amayeza kunye nezongezo ezonyusa i-serotonin, inokunyusa iziphumo kunye neziphumo ebezingalindelekanga. Ezinye zazo zibandakanya i-5-HTP, i-Hawaiian baby woodrose, kunye ne-S-adenosylmethionine (SAMe).

Wort yaseSt

Ukudibanisa i-L-tryptophan kunye ne-St. John's wort kunokunyusa umngcipheko we-serotonin syndrome, imeko enokubulala eyenzeka xa kukho i-serotonin eninzi emzimbeni. Kukho ingxelo yesifo se-serotonin kwisigulana esithathe i-L-tryptophan kunye namayeza aphezulu eSt.

Akukho kunxibelelana kwaziwayo nokutya.

Ezinye iimveliso zokutya ezinokuthi zingadwelisi i-L-tryptophan ngokwahlukileyo kwileyibhile. Endaweni yoko, inokudweliswa phantsi kwe-niacin. I-Niacin ilinganiswa ngokulingana ne-niacin (NE). I-60 mg ye-L-tryptophan iyafana ne-1 mg NE.

Idosi efanelekileyo ye-L-tryptophan ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi ze-L-tryptophan. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa. I-L-Triptofano, L-Trypt, L-2-amino-3- (indole-3-yl) propionic acid, L-Tryptophane, Tryptophan.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UMartínez-Rodríguez A, uRubio-Arias JÁ, uRamos-Campo DJ, uReche-García C, uLeyva-Vela B, uNadal-Nicolás Y. Iziphumo zengqondo kunye nokulala kweTrptptan kunye neMagnesium-eyandisiweyo yokutya kweMeditera kwabafazi abaneFibromyalgia. I-Int J En Res Res yezeMpilo yoLuntu. 2020; 17: 2227. Jonga i-abstract.
2. URazeghi Jahromi S, Togha M, Ghorbani Z, okqhubekayo. Umanyano phakathi kokutya i-tryptophan intake kunye ne-migraine. Neurol Sci. Ngo-2019; 40: 2349-55. Jonga i-abstract.
3. Ullrich SS, Fitzgerald PCE, Giesbertz P, Steinert RE, Horowitz M, Feinle-Bisset C.Iziphumo zolawulo lwe-intragastric ye-tryptophan kwimpendulo yeglucose kwisiselo esinxilisayo kunye nokutya amandla, kumadoda atyebileyo kwaye atyebileyo. Izondlo 2018; 10. IPH: E463. Jonga i-abstract.
4. UOshima S, uShiiya S, uNakamura Y.Iserum uric acid yokwehlisa iziphumo zokudityaniswa kwe-glycine kunye nonyango lwe-tryptophan kwizifundo ezine-hyperuricemia encinci: isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo, isifundo se-crossover. Izondlo 2019; 11. pii: E564. Jonga i-abstract.
5. ICynober L, Bier DM, Kadowaki M, Morris SM Jr, Elango R, Smriga M. Izindululo zemida ephezulu yokutya okukhuselekileyo kwe-arginine kunye ne-tryptophan kubantu abadala abancinci kunye nomda ophezulu wokutya okukhuselekileyo kwe-leucine kubantu abadala. J Amanqatha 2016; 146: 2652S-2654S. Jonga i-abstract.
6. UWang D, uLi W, uXiao Y, et al. I-Tryptophan yesifo sokulala kunye neempawu zengqondo zohlobo olutsha lokuxhomekeka kweziyobisi: ityala elingahleliwe, elingaboniyo, elilawulwa yi-placebo. Amayeza (iBaltimore) 2016; 95: e4135. Jonga i-abstract.
7. USayinio EL, uPulkki K, uSN omncinci. L-tryptophan: imichiza ye-biochemical, isondlo kunye nekhemesti. IiAmino Acids 1996; 10: 21-47. Jonga i-abstract.
8. UJavierre C, uSegura R, uVentura JL, uSuárez A, uRosés JM. Ukuxhaswa kwe-L-tryptophan kunokunciphisa ukukhathala kwengqondo ngexesha lokuzilolonga kwe-aerobic kunye ne-supramaximal intercalated bouter anaerobic kumadoda aselula asempilweni. Int J Neurosci. Ngo-2010 ngoMeyi; 120: 319-27. Jonga i-abstract.
9. IHiratsuka C, uSano M, uFukuwatari T, uShibata K. Iziphumo ezixhomekeke kwixesha lolawulo lwe-L-tryptophan kulawulo lokuchama kwe-L-tryptophan metabolites. J Amanqatha eSci Vitaminol (eTokyo). Ngo-2014; 60: 255-60. Jonga i-abstract.
10. UHiratsuka C, Fukuwatari T, Sano M, Saito K, Sasaki S, Shibata K. Ukongezwa kwabasetyhini abasempilweni ukuya kuthi ga kwi-5.0 g / d ye-L-tryptophan ayinaziphumo zibi. J Isondlo. Ngo-2013 uJuni; 143: 859-66. Jonga i-abstract.
11. URondanelli M, uOpizzi A, uFaliva M, et al. Iziphumo zokudityaniswa kokutya kunye ne-emulsion enamafutha ye-DHA-phospholipids equlathe i-melatonin kunye ne-tryptophan kwizigulana ezindala ezinengxaki yokuphazamiseka kwengqondo. I-Neurosci 2012; 15: 46-54.
12. UCelinski, K., Konturek, SJ, Konturek, PC, Brzozowski, T., Cichoz-Lach, H., Slomka, M., Malgorzata, P., Bielanski, W., kunye noReiter, uRJ Melatonin okanye uL-tryptophan uyakhawulezisa. ukuphiliswa kwezilonda ze-gastroduodenal kwizigulana eziphathwe nge-omeprazole. J. IPineal Res. Ngo-2011; 50: 389-394. Jonga i-abstract.
13. UKorner E, uBertha G, uFlooh E, et al. Umphumo wokulala olalisa i-L-tryptophane. I-Eur Neurol 1986; 25 iSuppl 2: 75-81. Jonga i-abstract.
14. I-Bryant SM, i-Kolodchak J.I-Serotonin syndrome ebangelwa yi-cocktail ye-herbal detox. NdinguJ Emerg Med 2004; 22: 625-6. Jonga i-abstract.
15. UCarr L, uRuther E, uBerg PA, uLehnert H. Eosinophilia-myalgia syndrome eJamani: uphononongo lwezifo. Ikliniki ye-Mayo ye-1994; 69: 620-5. Jonga i-abstract.
16. UMayeno AN, uGleich GJ. Isifo i-eosinophilia-myalgia syndrome: izifundo ezivela eJamani. Ikliniki yaseMayo 1994; 69: 702-4. Jonga i-abstract.
17. Shapiro S.Izifundo ze-Epidemiologic zombutho we-L-tryptophan kunye ne-eosinophilia-myalgia syndrome: i-critique. J Rheumatol Suppl 1996; 46: 44-58. Jonga i-abstract.
18. IHorwitz RI, uDaniels SR. I-Bias okanye i-biology: kuvavanywa izifundo zesifo se-L-tryptophan kunye ne-eosinophilia-myalgia syndrome. J Rheumatol Suppl 1996; 46: 60-72. Jonga i-abstract.
19. I-Kilbourne EM, uPhilen RM, uKamb ML, uFalk H. Tryptophan oveliswe nguShowa Denko kunye nobhubhane we-eosinophilia-myalgia syndrome. J Rheumatol Suppl 1996; 46: 81-8. Jonga i-abstract.
20. van Praag HM. Ulawulo loxinzelelo kunye nabanduleli be-serotonin. I-Biol Psychiatry 1981; 16: 291-310 .. Jonga i-abstract.
21. UWalinder J, uSkott A, uCarlsson A, et al. Ukubakho kwesenzo sokulwa noxinzelelo lwe-clomipramine yi-tryptophan. I-Arch Gen Psychiatry 1976; 33: 1384-89 .. Jonga i-abstract.
22. UMurphy FC, uSmith KA, uCowen PJ, et al. Iziphumo zokupheliswa kwe-tryptophan kulwazelelo kunye nokusebenza okusebenzayo kumavolontiya asempilweni. I-Psychopharmacology (Berl) 2002; 163: 42-53 .. Jonga i-abstract.
23. IBell C, Abrams J, Nutt D.Ukuzama ukupheliswa kwe-Tryptophan kunye neempembelelo zayo kunyango lwengqondo. Br J Psychiatry 2001; 178: 399-405 .. Jonga i-abstract.
24. UShaw K, Turner J, Del Mar C. Tryptophan kunye ne-5-hydroxytryptophan yoxinzelelo. Isiseko sedatha yeCochrane Sy Rev Rev 2002;: CD003198. Jonga i-abstract.
25. I-Simat TJ, i-Kleeberg KK, i-Muller B, i-Sierts A. Synthesis, ukuyilwa, kunye nokuvela kwezinto ezingcolileyo kwi-biotechnologically eyenziwe yi-L-tryptophan. Ugqwetha we-Exp Med Biol 1999; 467: 469-80 .. Jonga i-abstract.
26. I-Klein R, iBerg PA. Uphononongo lokuthelekisa kwii-antibodies kwi-nucleoli kunye ne-5-hydroxytryptamine kwizigulana ezine-fibromyalgia syndrome kunye ne-tryptophan-indos eosinophilia-myalgia syndrome. Iklinikhi yoPhando 1994; 72: 541-9 .. Jonga i-abstract.
27. UPriori R, uConti F, uLuan FL, et al. Ukudinwa okungapheliyo: uguquko olukhethekileyo lwe-eosinophilia myalgia syndrome kulandela unyango nge-L-tryptophan kulutsha lwase-Italiya. I-Eur J Pediatr 1994; 153: 344-6 .. Jonga i-abstract.
28. IGreenberg AS, Takagi H, Hill RH, et al. Ukulibaziseka kokuqala kwe-fibrosis yolusu emva kokufakwa kwe-eosinophilia-myalgia syndrome enxulumene ne-L-tryptophan. Ndiyi-Acad Dermatol 1996; 35: 264-6. Jonga i-abstract.
29. I-Ghose K. l-Tryptophan kwi-hyperactive syndrome yomntwana ehambelana nesifo sokuwa: isifundo esilawulwayo. Neuropsychobiology 1983; 10: 111-4. Jonga i-abstract.
30. UBornstein RA, i-Baker GB, uCarroll A, et al. Ii-amino acid zePlasma ekuqwalaseleni ukungahambi kakuhle. I-Psychiatry Res 1990; 33: 301-6 .. Jonga okungafakwanga.
31. I-Singhal AB, i-Caviness VS, i-Begleiter AF, okqhubekayo. I-vasoconstriction yeCerebral kunye nokubetha emva kokusetyenziswa kweziyobisi ze-serotonergic. Neurology 2002; 58: 130-3. Jonga i-abstract.
32. I-Bohme A, iWolter M, iHoelzer D.L-tryptophan-eosinophilia-myalgia syndrome enxulumene nesifo esingapheliyo se-B-lymphocytic leukemia. UAnn Hematol 1998; 77: 235-8.
33. UPhilen RM, Hill RH, Flanders WD, et al. I-Tryptophan ukungcola okunxulunyaniswa ne-eosinophilia-myalgia syndrome. NdinguJ Epidemiol 1993; 138: 154-9. Jonga i-abstract.
34. USullivan EA, uKamb ML, uJones JL, okqhubekayo. Imbali yendalo ye-eosinophilia-myalgia syndrome kwi-tryptophan-expression cohort eSouth Carolina. IArch Intern Med 1996; 156: 973-9. Jonga i-abstract.
35. IHatch DL, iGoldman LR. Ukunciphisa ubunzima be-eosinophilia-myalgia syndrome ehambelana nokusetyenziswa kwezongezelelo ezinamavithamini ngaphambi kokugula. IArch Intern Med 1993; 153: 2368-73. Jonga i-abstract.
36. I-Shapiro S. L-tryptophan kunye ne-eosinophilia-myalgia syndrome. ILancet 1994; 344: 817-9.
37. I-Hudson JI, uPopu HG, uDaniels SR, uHorwitz RI. I-Eosinophilia-myalgia syndrome okanye i-fibromyalgia ene-eosinophilia? IJAMA 1993; 269: 3108-9. Jonga i-abstract.
38. U. S. Ukutya kunye noLawulo lweeDrug, iZiko loKhuseleko loKutya kunye ne-Applied Nutrition, iOfisi yeeMveliso zeSondlo, ukuleyibhelisha, kunye neziXhobo zokuTya. IPhepha loLwazi kwi-L-Tryptophan kunye ne-5-hydroxy-L-tryptophan, ngoFebruwari 2001.
39. AM waseGhadirian, uMurphy BE, uGendron MJ. Ukusebenza kokukhanya xa kuthelekiswa nonyango lwe-tryptophan kunyango lokuchaphazeleka kwexesha. J Ukuchaphazela ukungaboni ngasonye 1998; 50: 23-7. Jonga i-abstract.
40. I-Steinberg S, i-Annable L, i-SN encinci, i-Liyanage N. Uphononongo olulawulwa yi-placebo lweziphumo ze-L-tryptophan kwizigulana ezinedysphoria yangaphambi kokuya exesheni. Ugqwetha we-Exp Med Biol 1999; 467: 85-8. Jonga i-abstract.
41. UNardini M, uDe Stefano R, uIannuccelli M, et al. Unyango loxinzelelo nge-L-5-hydroxytryptophan edityaniswe ne-chlorimipramine, isifundo esingaboni kabini. I-Int J Clin Pharmacol Res 1983; 3: 239-50. Jonga i-abstract.
42. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukufakwa kwereferensi yokutya kwi-Thiamin, i-Riboflavin, i-Niacin, i-Vitamin B6, i-Folate, i-Vitamin B12, i-Pantothenic Acid, i-Biotin kunye ne-Choline. IWashington, DC: ICandelo leSizwe lezeMfundo, 2000. Iyafumaneka kwi: http://books.nap.edu/books/0309065542/html/.
43. IHartmann E, iSpinweber CL. Ukulala okubangelwa yi-L-tryptophan. Iziphumo zeedosi kwisitya esiqhelekileyo sokutya. UJ Nerv Ment Dis 1979; 167: 497-9. Jonga i-abstract.
44. Seltzer S, Dewart D, Pollack R, Jackson E. Iziphumo zokutya tryptophan kwiintlungu ezingapheliyo ze-maxillofacial kunye novavanyo lokunyamezeleka kwentlungu. J Psychiatr Res 1982-83; 17: 181-6. Jonga i-abstract.
45. ISchmidt HS. L-tryptophan kunyango lokuphefumla okungalunganga xa ulele. Inkunzi ye-Eur Physiopathol Respir 1983; 19: 625-9. Jonga i-abstract.
46. Lieberman HR, Corkin S, Intwasahlobo BJ. Iziphumo zokutya kwe-neurotransmitter eyandulelayo kwindlela yokuziphatha kwabantu. NdinguJ J Clin Nutriti 1985; 42: 366-70. Jonga i-abstract.
47. UDevoe LD, uCastillo RA, uSearle NS. Iziqwengana zokutya koomama kunye nomsebenzi wosana olungekazalwa olusebusweni. Iziphumo ze-tryptophan kunye ne-glucose kwiintshukumo zokuphefumla komntwana. NdinguJ Obstet Gynecol 1986; 155: 135-9. Jonga i-abstract.
48. UMesshaha FS. I-Fluoxetine: Iziphumo ezibi kunye nokunxibelelana kweziyobisi. J Ityhefu yeCoxicol Clin 1993; 31: 603-30. Jonga i-abstract.
49. Isitokhwe seJW, uMcCall D Jr., iGoss AJ. Iziphumo zokuncedisa i-L-tryptophan kunye nemiyalelo yokutya kwiintlungu ezingapheliyo ze-myofascial. J Ndenze i-Assoc 1989; 118: 457-60. Jonga i-abstract.
50. I-Etzel KR, iStockstill JW, uRugh JD. Isongezelelo se-Tryptophan sasebusuku bruxism: ingxelo yeziphumo ezibi. J Craniomandib Disord 1991; 5: 115-20. Jonga i-abstract.
51. I-Bowen DJ, i-Spring B, i-Fox E. Tryptophan kunye nokutya okuphezulu kwe-carbohydrate njengezilungiso ekuyekeni ukutshaya. J Behav Med 1991; 14: 97-110. Jonga i-abstract.
52. I-Delgado PL, Ixabiso le-LH, iMiller HL. I-Serotonin kunye ne-neurobiology yoxinzelelo. Iziphumo zokuzama ukupheliswa kwe-tryptophan kwizigulana ezidandathekileyo ngaphandle kweziyobisi. IArch Gen Psychiatr 1994; 51: 865-74. Jonga i-abstract.
53. van Hall G, Raaymakers JS, Saris WH. Ukungeniswa kwee-amino acid ze-branched-chain kunye ne-tryptophan ngexesha lokuzilolonga okuzinzileyo emntwini: ukusilela ukuchaphazela ukusebenza. J Physiol (Umlenze) 1995; 486: 789-94. Jonga i-abstract.
54. ISharma RP, iShapiro LE, iKamath SK. Ukutya okuphelelweyo kwe-tryptophan depletion: Iziphumo kwi-schizophrenic positive kunye neempawu ezimbi. I-Neuropsychobiol 1997; 35: 5-10. Jonga i-abstract.
55. USmith KA, uFairburn CG, uCowen PJ. Ukubuyela umva kweempawu kwi-bulimia nervosa kulandela ukuphelelwa ngamandla kwe-tryptophan. IArch Gen Psychiatr 1999; 56: 171-6. Jonga i-abstract.
56. Foster S, uTyler VE. I-Herbal ethembekileyo yeTyler: Isikhokelo esiSebenzisayo sokuSebenzisa iiHerbs kunye neZonyango ezinxulumene noko. I-3rd ed., IBinghamton, NY: I-Haworth Herbal Press, ngo-1993.

Ukuhlaziywa okokugqibela-09/09/2020